BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
3.100
+0.060 (1.97%)
Feb 4, 2026, 12:56 PM EST - Market open

Revenue by Product

Millions ILA. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021
Period Ending
Dec '23 Dec '10 Dec '09
License
17.00M
Oncology and Hematology
700.72K
Oncology and Hematology Growth
-99.38%

Revenue by Geography

Millions ILA. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021
Period Ending
Dec '23 Dec '10 Dec '09
Israel
17.70M
Israel Growth
-84.36%